Summary: Methods
/ml in a comterm changes in progenitor cells following G-CSF injecmercially available methycellulose-based clonogenic assay tions and this information is important for optimizing colmedium (StemCell Technologies Inc, Metachem Diagnoslection protocols. In this study the short-term effects of glytics Ltd, Northampton, UK) with added recombinant cosylated G-CSF at a dose of 5 g/kg s.c. have been growth factors (stem cell factor, 10 ng/ml; IL-3, 30 ng/ml; investigated in healthy volunteers.
GM-CSF, 25 ng/ml; and erythroprotein, 3 U/ml). GM-CFC and burst-forming units-erythroid (BFU-E) were simultaneously evaluated after 14 days incubation at 37°C in a humidified 4% CO 2 atmosphere as previously described.
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To ensure consistency, a single batch of reagents was used throughout the study. All cultures were scored blindly to eliminate observer bias.
In the first phase of the study, CD34 + cell enumeration involves cytocentrifuge preparations, made from approxi- with a CD34 monoclonal antibody (HPCA-2; Becton Dickinson, Cowley, UK) and alkaline phosphatase-antialkaline phosphatase (APAAP) color development as described previously. 6 A 'Miller's squares' eyepiece (Graticules, Tonbridge, UK) was used to count the number of stained cells in a total of 10 000 cells examined. In the second phase of the study CD34 + cells were enumerated by flow cytometry as described previously using a phycoerythrin-conjugated CD34 monoclonal antibody (HPCA-2) and appropriate controls in a whole blood lysis method.

Statistical analysis
Comparison of values before and after G-CSF administration was performed by paired t-test.
Results
We have previously reported the daily changes in the WBC, CD34
+ cell and GM-CFC counts following 6 days of glycosylated G-CSF (lenograstim) at a dose of 5 g/kg s.c. in the 20 normal healthy controls included in the first phase. 6 Peak levels of CD34
+ cells GM-CFC and BFU-E were observed on days 5-7 with the peak levels occurring more frequently on day 6. On days 4, 5 and 6, blood samples were taken immediately before the next dose of G-CSF and 2 h later. This revealed a significant fall in the white count at the 2-h time-points (data not shown) which was due almost entirely to a fall in the neutrophil count (Figure 1a ). There was a simultaneous fall in the GM-CFC levels ( Figure 1b ) and whereas on day 5 the fall was only 8% (P = 0.07) by day 6 this fall was 38% (P = 0.007).
To investigate this phenomenon in more detail, a further six normal individuals were administered lenograstim 5 g/kg s.c. for 6 days and on day 6 blood samples were taken immediately before the last dose of G-CSF and at nine time-points over the next 24 h. Day 6 was chosen for study as this was the most frequent day of peak mobiliz- being maximal at 1 h after the G-CSF injection. Baseline levels were achieved by 3 h and subsequently rose to approximately 150% at 12 h after the injection (Figure 2 ). point after G-CSF injection on days 4, 5 and 6. This is in accord with previous studies 5, 8 and presumably reflects CD34 + cells, GM-CFC and BFU-E also fell to a nadir at 1 h and rose to baseline levels over the next 4-12 h. The rapid changes in neutrophil adhesion molecule expression and function. 9 In this study a simultaneous fall in GM-CFC fall in progenitor cells at 1 h was seen as a trend for BFU-E (P = 0.066) and was significant for CD34 + cells was observed and this is confirmed in the more detailed analysis of six patients studied on day 6 in the second phase (P = 0.034) and GM-CFC (P = 0.025).
of the study. The kinetics of the changes in neutrophils and progenitor cells were different however in that the neutrophil count recovered more quickly to the pre-injection levDiscussion els. It is notable that between 12 and 24 h post-G-CSF on day 6 there was a secondary fall in neutrophil and progeniPrevious studies by ourselves and others have shown that optimal progenitor cell mobilization after daily G-CSF tor levels. The reason for this is not fully clear but may merely represent the fact that the time of peak mobilization administration to normal volunteers occurs on days 5-7. 5, 6, 8 There is less information about the short-term kinetics of had passed, in line with previous data.
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PBPC harvesting is usually performed on several conwhite cell and progenitor cell changes after G-CSF administration on the days on which harvesting can be performed.
secutive days and if on a given day, a collection on the next day is also planned then further G-CSF is usually In the first phase of our study in 20 normal volunteers, a fall in the neutrophil count was observed at the 2 h time-
given. This study indicates that if optimal levels of progeni-days 4, 5 and 6 but was not significant. It is not known whether this represents a difference in the magnitude in the effect compared to glycosylated G-CSF or represents a change in the kinetics of the effect. Detailed kinetics with non-glycosylated G-CSF were not performed. It should also be noted that the kinetics and magnitude of any G-CSFinduced fall in progenitor cells could differ in heavily pretreated individuals.
The mechanism of the G-CSF-mediated fall in progenitor cells is not known but the speed of fall suggests that it may be margination in the periphery analogous to the GM-CSFinduced transient neutropenia demonstrated to be due to margination by radioactive labelling studies. 16 Levesque et al 17 have shown that GM-CSF, IL-3 and SCF activate ␤ 1 integrins on CD34 + cells, but no effect was observed with G-CSF. It is possible that G-CSF activates other adhesion molecules.
In conclusion, this study shows that there is a transient fall in progenitor cell levels following injection of glycosylated G-CSF at a dose of 5 g/kg/day s.c. and that recovery types of G-CSF at other doses if optimal harvesting schedules are to be established. tor cells are to be collected the G-CSF should not be given immediately prior to that day's collection. As apheresis yields are closely related to blood progenitor counts, 11 if References G-CSF is given at the start of leukopheresis the progenitor cell yield is likely to be reduced by 15-30%. In most indi-
